We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
David Korn David is vice president, intellectual property and law at PhRMA where he focuses on intellectual property related policy issues. He previously practiced intellectual property and food and drug law at Arnold & Porter LLP. Mr. Korn has undergraduate and graduate degrees in biomedical engineering from Duke University and Northwestern University' and a law degree from Harvard Law School. He served as a law clerk to the Honorable Caleb Wright on the U.S. District Court for the District of Delaware prior to joining Arnold & Porter.
Last week, I presented at the U.S Food and Drug Administration’s (FDA) public meeting on the Hatch-Waxman Amendments to discuss the balance between encouraging innovation in biopharmaceutical...